{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:53:58Z","timestamp":1780426438186,"version":"3.54.1"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/med.0b013e32833f47e4","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T06:44:46Z","timestamp":1294987486000},"page":"554-560","source":"Crossref","is-referenced-by-count":11,"title":["Primary hyperparathyroidism: an update"],"prefix":"10.1097","volume":"17","author":[{"given":"Zeina","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20211004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/jc.2008-1757","article-title":"The diagnosis and management of asymptomatic primary hyperparathyroidism revisited","volume":"94","author":"Khan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-11-20211004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-11-20211004","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u2018Incipient\u2019 primary hyperparathyroidism: a \u2018forme fruste\u2019 of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-11-20211004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R5-11-20211004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"R6-11-20211004","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism: a current perspective","volume":"132","author":"DeLellis","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"R7-11-20211004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00268-009-0294-x","article-title":"Role of growth factors on human parathyroid adenoma cell proliferation","volume":"34","author":"Cavallaro","year":"2010","journal-title":"World J Surg"},{"key":"R8-11-20211004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-1-4419-1664-8_8","article-title":"The role of menin in parathyroid tumorigenesis","volume":"668","author":"Davenport","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"R9-11-20211004","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cca.2009.05.023","article-title":"Calcium-sensing receptor autoantibodies in primary hyperparathyroidism","volume":"406","author":"Charrie","year":"2009","journal-title":"Clin Chim Acta"},{"key":"R10-11-20211004","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00268-009-0044-0","article-title":"Hyperparathyroidism and malnutrition with severe vitamin D deficiency","volume":"33","author":"Agarwal","year":"2009","journal-title":"World J Surg"},{"key":"R11-11-20211004","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.surg.2007.09.026","article-title":"Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism","volume":"142","author":"Untch","year":"2007","journal-title":"Surgery"},{"key":"R13-11-20211004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jamcollsurg.2009.12.017","article-title":"Primary hyperparathyroidism from parathyroid microadenoma: specific features and implications for a surgical strategy in the era of minimally invasive parathyroidectomy","volume":"210","author":"Goasguen","year":"2010","journal-title":"J Am Coll Surg"},{"key":"R14-11-20211004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archoto.2009.225","article-title":"The impact of baseline intact parathyroid hormone levels on severity of primary hyperparathyroidism and outcomes in patients undergoing surgery","volume":"136","author":"Kandil","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R15-11-20211004","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lary.20180","article-title":"Assessing the impact of low baseline parathyroid hormone levels on surgical treatment of primary hyperparathyroidism","volume":"119","author":"Clark","year":"2009","journal-title":"Laryngoscope"},{"key":"R16-11-20211004","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.surg.2009.09.009","article-title":"Neurocognitive dysfunction: a predictor of parathyroid hyperplasia","volume":"146","author":"Repplinger","year":"2009","journal-title":"Surgery"},{"key":"R17-11-20211004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jss.2008.07.041","article-title":"Sporadic primary hyperparathyroidism in young individuals: different disease and treatment?","volume":"155","author":"Sneider","year":"2009","journal-title":"J Surg Res"},{"key":"R18-11-20211004","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.surg.2009.09.024","article-title":"Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism","volume":"146","author":"Heyliger","year":"2009","journal-title":"Surgery"},{"key":"R19-11-20211004","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-11-20211004","first-page":"241","article-title":"Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism","volume":"16","author":"Vazquez-Diaz","year":"2009","journal-title":"Cardiol J"},{"key":"R21-11-20211004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10554-008-9369-2","article-title":"Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients","volume":"25","author":"Kepez","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"R22-11-20211004","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/EJE-09-0069","article-title":"Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism","volume":"160","author":"Erem","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R23-11-20211004","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-11-20211004","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2009-1669","article-title":"The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment","volume":"95","author":"Virdis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-11-20211004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF03346518","article-title":"Endothelial function and endothelial nitric oxide synthase intron 4a\/b polymorphism in primary hyperparathyroidism","volume":"32","author":"Ekmekci","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R26-11-20211004","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.surg.2009.09.041","article-title":"Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism","volume":"146","author":"Brunaud","year":"2009","journal-title":"Surgery"},{"key":"R27-11-20211004","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP.14.1.69","article-title":"Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism","volume":"14","author":"Cardenas","year":"2008","journal-title":"Endocr Pract"},{"key":"R28-11-20211004","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1464-5491.2009.02804.x","article-title":"Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism","volume":"26","author":"Tassone","year":"2009","journal-title":"Diabet Med"},{"key":"R29-11-20211004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.2009.03558.x","article-title":"Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women","volume":"71","author":"Ahlstrom","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R30-11-20211004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF03345719","article-title":"Cardiovascular risk factors in primary hyperparathyroidism","volume":"32","author":"Luboshitzky","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R31-11-20211004","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1017\/S1355617709990695","article-title":"Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy","volume":"15","author":"Benge","year":"2009","journal-title":"J Int Neuropsychol Soc"},{"key":"R32-11-20211004","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/jc.2008-2574","article-title":"Neuropsychological features in primary hyperparathyroidism: a prospective study","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R33-11-20211004","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/BF03345742","article-title":"High prevalence of simple kidney cysts in patients with primary hyperparathyroidism","volume":"32","author":"Corbetta","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R34-11-20211004","first-page":"1480","article-title":"Hypocalciuria in overt and subclinical celiac disease","volume":"90","author":"Ciacci","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R35-11-20211004","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2008-2430","article-title":"Calcium-sensing receptor (CaSR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years","volume":"95","author":"Guarnieri","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-11-20211004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-11-20211004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF03346498","article-title":"Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition","volume":"32","author":"Vierimaa","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"R38-11-20211004","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1507\/endocrj.K08E-265","article-title":"MEN1 gene analysis in patients with primary hyperparathyroidism: 10-year experience of a single institution for thyroid and parathyroid care in Japan","volume":"56","author":"Kihara","year":"2009","journal-title":"Endocr J"},{"key":"R39-11-20211004","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R40-11-20211004","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.surg.2007.09.025","article-title":"Impact of 25 hydroxyvitamin D deficiency in perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism","volume":"142","author":"Perrier","year":"2007","journal-title":"Surgery"},{"key":"R41-11-20211004","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hed.21082","article-title":"Role of vitamin D deficiency in continued hyperparathyroidism following parathyroidectomy","volume":"31","author":"Redman","year":"2009","journal-title":"Head Neck"},{"key":"R42-11-20211004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12020-009-9211-1","article-title":"Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency","volume":"36","author":"Isidro","year":"2009","journal-title":"Endocrine"},{"key":"R43-11-20211004","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-11-20211004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1530\/EJE-08-0901","article-title":"Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D","volume":"161","author":"Tucci","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R45-11-20211004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"R47-11-20211004","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R48-11-20211004","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R49-11-20211004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4158\/EP08178.ORR","article-title":"Alendronate therapy in men with primary hyperparathyroidism","volume":"15","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"key":"R50-11-20211004","first-page":"729","article-title":"The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis","volume":"48","author":"Han","year":"2009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"R51-11-20211004","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R52-11-20211004","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-11-20211004","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.2008-2640","article-title":"Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism","volume":"94","author":"Marcocci","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-11-20211004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/lary.20706","article-title":"Parathyroidectomy in the elderly population: does age really matter?","volume":"120","author":"Young","year":"2010","journal-title":"Laryngoscope"},{"key":"R55-11-20211004","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jamcollsurg.2009.01.048","article-title":"Outpatient minimally invasive parathyroidectomy is safe for elderly patients","volume":"208","author":"Shin","year":"2009","journal-title":"J Am Coll Surg"},{"key":"R56-11-20211004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-08-0523","article-title":"Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients","volume":"160","author":"Norenstedt","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"R57-11-20211004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01623394","article-title":"Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report","volume":"6","author":"Diamond","year":"1996","journal-title":"Osteoporos Int"},{"key":"R58-11-20211004","first-page":"3487","article-title":"Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism","volume":"81","author":"Guo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-11-20211004","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"R60-11-20211004","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"key":"R61-11-20211004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-11-20211004","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R63-11-20211004","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00774-008-0033-7","article-title":"Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy","volume":"27","author":"Boudou","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"R64-11-20211004","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00268-008-9720-8","article-title":"Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism","volume":"33","author":"VanderWalde","year":"2009","journal-title":"World J Surg"},{"key":"R65-11-20211004","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.juro.2009.01.028","article-title":"Patients with primary hyperparathyroidism: why do some form stones?","volume":"181","author":"Berger","year":"2009","journal-title":"J Urol"},{"key":"R66-11-20211004","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1464-410X.2008.08064.x","article-title":"Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism","volume":"103","author":"Parks","year":"2009","journal-title":"BJU Int"},{"key":"R67-11-20211004","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SLA.0b013e3181d76bb3","article-title":"Parathyroidectomy improves functional capacity in \u2018asymptomatic\u2019 older patients with primary hyperparathyroidism: a randomized control trial","volume":"251","author":"Morris","year":"2010","journal-title":"Ann Surg"},{"key":"R68-11-20211004","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.surg.2009.09.034","article-title":"Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with \u2018asymptomatic\u2019 primary hyperparathyroidism","volume":"146","author":"Perrier","year":"2009","journal-title":"Surgery"},{"key":"R69-11-20211004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.surge.2009.10.005","article-title":"Health-related quality of life improvement following surgical treatment of primary hyperparathyroidism in a United Kingdom population","volume":"8","author":"Leong","year":"2010","journal-title":"Surgeon"},{"key":"R70-11-20211004","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.surg.2009.10.021","article-title":"The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study","volume":"146","author":"Pasieka","year":"2009","journal-title":"Surgery"},{"issue":"Suppl 2","key":"R71-11-20211004","first-page":"N154","article-title":"The basis for the postparathyroidectomy increase in bone mass","volume":"17","author":"Heaney","year":"2002","journal-title":"J Bone Miner Res"}],"container-title":["Current Opinion in Endocrinology, Diabetes & Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201012000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T01:30:12Z","timestamp":1633311012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201012000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/med.0b013e32833f47e4","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}